维普中文期刊产品整合服务
25篇 您的检索式:作者名="Remiszewski"
    题名 作者 年代 出处 被引量
1Epithelioid hemangioendothelioma of the liver as a rare indication for liver transplantation显示文摘AIM: To investigate the indications and outcomes of liver transplantation for hepatic epithelioid hemangioendothelioma(HEHE). METHODS: Between 1989 and August 2013, in the Department of General, Transplant, and Liver Surgery, Medical University of Warsaw, 1306 orthotopic liver transplantations(OLTx) were performed, including 72 retransplantations. Unresectable HEHE was an indication for OLTx in 10 patients(0.8% of primary OLTx), the mean age of the patients was 40.5 ± 13.3 years(range 23-65 years), and the male-to-female ratio was 2:8. Kaplan-Meier survival analysis in HEHE, hepatocellular carcinoma(HCC), and other OLTx recipients groups was performed. The differences in mortality were compared using the χ2 test. A P-value < 0.05 indicated statistical significance.RESULTS: No concomitant liver disease was found in any patient. There was no neoadjuvant chemotherapy or radiotherapy. Liver function test results were normal in most of the patients. The levels of alpha-fetoprotein, carcinoembryonic antigen, and carbohydrate antigen 19-9 were normal. In immunohistochemical staining, the neoplastic cells were positive for factor Ⅷ-related antigen, CD31, and CD34, which are endothelial cell markers, and negative for cytokeratin 19, cytokeratin 7, and HepPar-1. Nine patients were alive without tumor recurrence. One patient died 2 mo after OLTx due to septic complications. No morbidity was observed. Maximum follow-up was 11.4 years, with a minimum of 1 mo. The cumulative survival rate at the end of followup in HEHE patients was 87.5% compared with 54.3% in the HCC group and 76.3% in the other OLTx recipients group(χ2 test = 1.784, df = 2, P = 0.409).CONCLUSION: Unresectable HEHE, without extrahepatic metastases is an excellent indication for liver transplantation. Long-term survival is very good and much better than in HCC patients and the entire group of OLTx patients.Piotr Remiszewski Ewa Szczerba Piotr Kalinowski Beata Gierej Krzysztof Dudek Mariusz Grodzicki Marcin Kotulski Rafa Paluszkiewicz Waldemar Patkowski Krzysztof Zieniewicz Marek Krawczyk 2014World Journal of Gastroenterology2014,20,32:10
2Simultaneous liver mucinous cystic and intraductal papillary mucinous neoplasms of the bile duct:A case report显示文摘Cystic hepatic neoplasms are rare tumors,and are classified into two separate entities:mucinous cystic neoplasms(MCNs)and intraductal papillary mucinous neoplasms of the bile duct(IPMN-B).We report the case of a 56-year-old woman who presented with abdominal pain and jaundice due to the presence of a large hepatic multilocular cystic tumor associated with an intraductal tumor.Partial hepatectomy with resection of extrahepatic bile ducts demonstrated an intrahepatic MCN and an intraductal IPMN-B.This is the first report of the simultaneous occurrence of these two histologically distinct entities in the liver.Agnieszka Budzynska Marek Hartleb Ewa Nowakowska-Dulawa Robert Krol Piotr Remiszewski Michal Mazurkiewicz 2014World Journal of Gastroenterology2014,20,14:2
3Fatal infec- tion in patients treated for small cell lung cancer in the institute of tuberculosis and chest diseases in the years 1980-1994显示文摘Remiszewski P Sodkowska J Wiatr E 2001Lung Cancer2001,31,23:1
4Organi- zing pneumonia-analysis of 18 own cases显示文摘Radzikowska E Wiatr E Remiszewski P 2004Pneumonol Alergol Pol2004,72,34:1
5Influence of Selected Factors on Survival After Liver Retransplantation显示文摘P. Remiszewski P. Kalinowski K. Dudek M. Grodzicki R. Paluszkiewicz K. Zieniewicz M. Krawczyk 2011Transplantation Proceedings2011,,8:1
6Reversible programming of pluripotent cell differentiation显示文摘Lake J Rathjen J Remiszewski J 2000J Cell Sci2000,113,:1
7Reversible programming ofpluripotent cell differentiation 显示文摘Lake JA Rathjen J Remiszewski J 2000J Cell Sci2000,113,:1
8Treatment of early hepatic artery thrombosis after liver transplantation显示文摘Grodzicki M Anysz-Grodzicka A Remiszewski P 0,,08:1
9Inhibitors of human histone decetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates显示文摘Remiszewski SW Sambucetti LC Atadja P 2002J Med Chem2002,45,4:1
10Orthotopic liver transplantation for acute liver failure resulting from“acute fatty liver of pregnancy”显示文摘Remiszewski P Pawlak J Skwarek A 2003Ann Transplant2003,8,3:1
11Orthotopic liver transplantation for acute liver failure resulting from“acute fatty liver of pregnancy”显示文摘Remiszewski P Pawlak J Skwarek A 2003Ann Transplant2003,8,3:1
12Inhibitors of human hidtone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates 显示文摘Remiszewski SW Sambucetti LC Atadja P 2002J Med Chem2002,45,4:1
13Pulmonary thromboembolism as the main or secondary cause of death in patients treated for small cell lung cancer显示文摘Remiszewski P Slodkowska J Wiatarr E 1999Pneumonol A Alergol Pol1999,67,:1
14Fatalinfection in patients treated for small cell lung cancer inthe Institute of Tuberculosis and Chest Diseases in theyears 1980-1994显示文摘Remiszewski P Sodkowska J Wiatr E 2001Lung Cancer2001,31,23:1
15The discovery of NVP-LAQ824:from concept to clinic显示文摘Remiszewski S W 2003Curr Med Chem2003,10,22:1
16Disseminated mycobacterium avium infection in a 20-year-old female with partial recessive IFNgammaR1 deficiency 显示文摘Remiszewski P Roszkowska-Sliz B Winek J 2006Respiration2006,73,:1
17The cause of infection as the main or additional cause of death in patients treated for small lung cancer显示文摘Remiszewski P Slodkoesra J Szczepek B 2000Pneumonal Alergol Pol2000,67,7:1
18Influence of selected factors on survival after liver retransplantation 显示文摘Remiszewski P Kalinowski P Dudek K 2011Transplant Proc2011,43,8:1
19Influence of selected factors on survival after liver retransplantation 显示文摘Remiszewski P Kalinowski P Dudek K 2011Transplant Proc2011,43,8:1
20Inhibitors of human hidtone deacetylase:synthesis and enzyme and cellular activity of straight chain hydroxamates显示文摘Remiszewski SW Sambucetti LC Atadja P 2002J Med Chem2002,45,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费